Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
006890.KS Stock Summary
Top 10 Correlated ETFs
006890.KS
In the News
006890.KS Financial details
Company Rating
Neutral
Market Cap
152.89B
Income
17.42B
Revenue
70.75B
Book val./share
14288.39
Cash/share
4672.03
Dividend
200
Dividend %
1.46%
Employees
87
Optionable
No
Shortable
Yes
Earnings
23 Jan 2024
P/E
9.69
Forward P/E
-
PEG
1
P/S
2.23
P/B
0.97
P/C
2.84
P/FCF
20.28
Quick Ratio
-
Current Ratio
4.71
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
1.54K
EPS next Y
-
EPS next Q
-
EPS this Y
96.44%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
12.37%
Revenue last 5Y
11.08%
Revenue Q/Q
-12.9%
EPS Q/Q
-44.7%
-
-
-
-
SMA20
3.37%
SMA50
0.83%
SMA100
1.71%
Inst Own
-
Inst Trans
-
ROA
9%
ROE
10%
ROC
0.1%
Gross Margin
45%
Oper. Margin
24%
Profit Margin
23%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
11440.0-16790.0
52W High
-21.02%
52W Low
+15.91%
RSI
51
Rel Volume
0.97
Avg Volume
34.2K
Volume
33.15K
Perf Week
-1.34%
Perf Month
1.3%
Perf Quarter
7.02%
Perf Half Y
5.74%
-
-
-
-
Beta
1.208
-
-
Volatility
197.11%, 277.31%
Prev Close
-0.15%
Price
13260
Change
1.53%
006890.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.65K | 4.14K | 4.77K | 5.26K | 6.24K | |
Net income per share | 857.74 | 681.1 | 963.01 | 782.4 | 1.54K | |
Operating cash flow per share | 2.9K | 772.85 | 1.18K | 893.46 | 1.8K | |
Free cash flow per share | 2.82K | 415.91 | 769.45 | 354.42 | 298.5 | |
Cash per share | 3.3K | 3.56K | 4.39K | 4.46K | 4.67K | |
Book value per share | 10.35K | 10.94K | 12.42K | 12.99K | 14.29K | |
Tangible book value per share | 10.35K | 10.9K | 12.4K | 12.94K | 14.23K | |
Share holders equity per share | 10.35K | 10.94K | 12.42K | 12.99K | 14.29K | |
Interest debt per share | 36.12 | 36.73 | 31.26 | 22.33 | 27.52 | |
Market cap | 60.12B | 160.68B | 139.97B | 117.31B | 156.63B | |
Enterprise value | 50.39B | 155.76B | 134.48B | 95.23B | 146.52B | |
P/E ratio | 6.12 | 20.78 | 12.82 | 13.23 | 8.99 | |
Price to sales ratio | 1.44 | 3.41 | 2.59 | 1.97 | 2.21 | |
POCF ratio | 1.81 | 18.31 | 10.46 | 11.58 | 7.7 | |
PFCF ratio | 1.86 | 34.02 | 16.05 | 29.2 | 46.3 | |
P/B Ratio | 0.51 | 1.29 | 0.99 | 0.8 | 0.97 | |
PTB ratio | 0.51 | 1.29 | 0.99 | 0.8 | 0.97 | |
EV to sales | 1.2 | 3.31 | 2.49 | 1.6 | 2.07 | |
Enterprise value over EBITDA | 1.52 | 12.71 | 8.01 | 6.22 | 7.25 | |
EV to operating cash flow | 1.52 | 17.75 | 10.05 | 9.4 | 7.2 | |
EV to free cash flow | 1.56 | 32.98 | 15.42 | 23.71 | 43.31 | |
Earnings yield | 0.16 | 0.05 | 0.08 | 0.08 | 0.11 | |
Free cash flow yield | 0.54 | 0.03 | 0.06 | 0.03 | 0.02 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.29 | -0.4 | -0.33 | -1.44 | -0.5 | |
Current ratio | 5.22 | 5.71 | 5.94 | 5.68 | 5.55 | |
Interest coverage | 882.22 | 687.75 | 974.94 | 1.27K | 1.88K | |
Income quality | 3.38 | 1.13 | 1.23 | 1.16 | 1.17 | |
Dividend Yield | 0.03 | 0.01 | 0.02 | 0.02 | 0.01 | |
Payout ratio | 0.18 | 0.22 | 0.21 | 0.28 | 0.13 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.03 | -0.46 | -0.35 | -0.6 | -0.83 | |
Capex to revenue | -0.02 | -0.09 | -0.09 | -0.1 | -0.24 | |
Capex to depreciation | -0.34 | -1.78 | -2.08 | -2.59 | -7.33 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 14.13K | 12.95K | 16.4K | 15.12K | 22.23K | |
ROIC | 0.21 | 0.05 | 0.07 | 0.05 | 0.09 | |
Return on tangible assets | 0.07 | 0.06 | 0.07 | 0.05 | 0.1 | |
Graham Net | 2.63K | 2.84K | 3.43K | 3.66K | 3.8K | |
Working capital | 41.27B | 42.89B | 51.78B | 54.5B | 56.51B | |
Tangible asset value | 118.49B | 123.78B | 140.54B | 146.69B | 161.28B | |
Net current asset value | 33.93B | 35.52B | 42.5B | 46.11B | 48.04B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 12.13B | 10.76B | 10.33B | 11.77B | 12.84B | |
Average payables | 3.27B | 2.52B | 2.34B | 2.4B | 2.47B | |
Average inventory | 2.24B | 1.68B | 1.71B | 2.26B | 2.79B | |
Days sales outstanding | 100.43 | 77.7 | 71.78 | 79.08 | 65.81 | |
Days payables outstanding | 34.12 | 27.28 | 29.68 | 22.96 | 24.41 | |
Days of inventory on hand | 21.21 | 19.89 | 21.6 | 27.16 | 26.34 | |
Receivables turnover | 3.63 | 4.7 | 5.08 | 4.62 | 5.55 | |
Payables turnover | 10.7 | 13.38 | 12.3 | 15.89 | 14.96 | |
Inventory turnover | 17.21 | 18.35 | 16.9 | 13.44 | 13.86 | |
ROE | 0.08 | 0.06 | 0.08 | 0.06 | 0.11 | |
Capex per share | -72.97 | -356.94 | -411.74 | -539.04 | -1.5K |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.39K | 1.39K | 1.63K | 1.72K | 1.5K | |
Net income per share | 101.92 | 459.67 | 441.77 | 409.19 | 226.3 | |
Operating cash flow per share | 356.16 | 248.04 | 1.09K | 256.8 | 196.97 | |
Free cash flow per share | 126.02 | 84.71 | 366.89 | -102.07 | -51.03 | |
Cash per share | 4.46K | 4.62K | 4.86K | 4.72K | 4.67K | |
Book value per share | 12.99K | 13.57K | 14.09K | 14.14K | 14.29K | |
Tangible book value per share | 12.94K | 13.52K | 14.04K | 14.09K | 14.23K | |
Share holders equity per share | 12.99K | 13.57K | 14.09K | 14.14K | 14.29K | |
Interest debt per share | 21.76 | -259.98 | 25.46 | 17.11 | 26.86 | |
Market cap | 117.31B | 161.17B | 169.9B | 135.33B | 156.63B | |
Enterprise value | 95.23B | 128.13B | 144.37B | 91.61B | 146.52B | |
P/E ratio | 25.39 | 7.73 | 8.48 | 7.29 | 15.27 | |
Price to sales ratio | 7.42 | 10.2 | 9.18 | 6.95 | 9.24 | |
POCF ratio | 29.06 | 57.33 | 13.71 | 46.5 | 70.16 | |
PFCF ratio | 82.13 | 167.86 | 40.86 | -116.98 | -270.83 | |
P/B Ratio | 0.8 | 1.05 | 1.06 | 0.84 | 0.97 | |
PTB ratio | 0.8 | 1.05 | 1.06 | 0.84 | 0.97 | |
EV to sales | 6.02 | 8.11 | 7.8 | 4.7 | 8.64 | |
Enterprise value over EBITDA | 31.35 | 19.46 | 16.57 | 9.4 | 36.76 | |
EV to operating cash flow | 23.59 | 45.58 | 11.65 | 31.48 | 65.63 | |
EV to free cash flow | 66.67 | 133.46 | 34.72 | -79.19 | -253.33 | |
Earnings yield | 0.01 | 0.03 | 0.03 | 0.03 | 0.02 | |
Free cash flow yield | 0.01 | 0.01 | 0.02 | -0.01 | 0 | |
Debt to equity | 0 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -7.27 | -5.02 | -2.93 | -4.49 | -2.54 | |
Current ratio | 5.68 | 5.22 | 4.17 | 4.71 | 5.55 | |
Interest coverage | 1.44K | -1.09 | 2.07K | 2.07K | 1.67K | |
Income quality | 3.59 | 0.54 | 2.48 | 0.63 | 0.87 | |
Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 0 | 0 | 0.45 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.2 | 0.2 | 0.19 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.65 | -0.66 | -0.66 | -1.4 | -1.26 | |
Capex to revenue | -0.17 | -0.12 | -0.44 | -0.21 | -0.17 | |
Capex to depreciation | -4.44 | -3.07 | -14.2 | -7.12 | -4.87 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.46K | 11.85K | 11.83K | 11.41K | 8.53K | |
ROIC | 0.01 | 0.02 | 0.03 | 0.03 | 0.02 | |
Return on tangible assets | 0.01 | 0.03 | 0.03 | 0.03 | 0.01 | |
Graham Net | 3.66K | 3.71K | 3.5K | 3.68K | 3.8K | |
Working capital | 54.5B | 56.21B | 54.32B | 55.4B | 56.51B | |
Tangible asset value | 146.69B | 153.27B | 159.12B | 159.69B | 161.28B | |
Net current asset value | 46.11B | 46.95B | 44.28B | 46.55B | 48.04B | |
Invested capital | 0 | 0 | 0 | 0 | 0 | |
Average receivables | 12.17B | 13.87B | 14.53B | 14.38B | 13.63B | |
Average payables | 2.17B | 2.31B | 2.33B | 2.3B | 2.46B | |
Average inventory | 2.43B | 2.51B | 2.22B | 2.18B | 2.56B | |
Days sales outstanding | 73.54 | 84.41 | 69.24 | 67.08 | 67.69 | |
Days payables outstanding | 22.18 | 22.72 | 21.49 | 20.9 | 22.69 | |
Days of inventory on hand | 26.23 | 22.71 | 19.43 | 20.81 | 24.49 | |
Receivables turnover | 1.22 | 1.07 | 1.3 | 1.34 | 1.33 | |
Payables turnover | 4.06 | 3.96 | 4.19 | 4.31 | 3.97 | |
Inventory turnover | 3.43 | 3.96 | 4.63 | 4.33 | 3.68 | |
ROE | 0.01 | 0.03 | 0.03 | 0.03 | 0.02 | |
Capex per share | -230.14 | -163.33 | -726.45 | -358.87 | -248 |
006890.KS Frequently Asked Questions
What is Taekyung Chemical Co., Ltd. stock symbol ?
Taekyung Chemical Co., Ltd. is a KR stock and trading under the symbol 006890.KS
What is Taekyung Chemical Co., Ltd. stock quote today ?
Taekyung Chemical Co., Ltd. stock price is $13260 today.
Is Taekyung Chemical Co., Ltd. stock public?
Yes, Taekyung Chemical Co., Ltd. is a publicly traded company.